Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors (Q38269843)

1 September 2017

1 reference

title

Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors (English)

1 reference

1 September 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Filippo de Braud

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Laura Botta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Massimo Broggini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Gemma Gatta

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ugo Pastorino

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Marina Garassino

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

D Serpico

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

A Trama

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

E R Haspinger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

F Agustoni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

G Palmieri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

P Zucali

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

R Gallucci

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

G Pelosi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

TYME (TYmic MalignanciEs) Collaborative Group

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

1 reference

19 November 2014

1 reference

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

838-847

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411417%20AND%20SRC:MED&resulttype=core&format=json

Rare thoracic cancers, including peritoneum mesothelioma

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Rare cancers are not so rare: the rare cancer burden in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Epidemiology of Thymoma and Associated Malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Follow-up study of thymomas with special reference to their clinical stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

A multidisciplinary approach to therapy for unresectable malignant thymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Advanced stage thymomas and thymic carcinomas: results of multimodality treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Thymic carcinoma with overexpression of mutated KIT and the response to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Dasatinib induces a response in malignant thymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Response of malignant thymoma to erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Thymic carcinoma with epidermal growth factor receptor gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Genetic profiling of thymic carcinoma using targeted next-generation sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Imatinib mesylate in thymic epithelial malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Phase I trial of SU14813 in patients with advanced solid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Somatostatin analogs and prednisone in advanced refractory thymic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Epidermal growth factor receptor expression in invasive thymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Mutational status of EGFR and KIT in thymoma and thymic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial neoplasms staged according to the 2004 World Health Organization in patients treated with octreotide and prednisone: an Eastern Cooperati

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Cetuximab is an active treatment of metastatic and chemorefractory thymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Thymic Tumors: Relevant Molecular Data in the Clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Chemotherapy and targeted agents for thymic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Long lasting efficacy of sorafenib in a heavily pretreated patient with thymic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

In Vitro Characterization of Somatostatin Receptors in the Human Thymus and Effects of Somatostatin and Octreotide on Cultured Thymic Epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Aberrant methylation of tumour-related genes in thymic epithelial tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527

Malignant transformation of thymoma in recipient rats by heterotopic thymus transplantation from HTLV-I transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU527